Home > Boards > US Listed > Banking and Finance > Ladenburg Thalmann Financial Services Inc. (LTS)

The third quarter numbers were very good and

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
investora2z Member Profile
 
Followed By 10
Posts 602
Boards Moderated 0
Alias Born 02/08/13
160x600 placeholder
Marinus Pharmaceuticals Announces Closing of $70 Million Public Offering of Common Stock and Concurrent Private Placement Inc... GlobeNewswire Inc. - 12/13/2019 4:01:10 PM
Securities America Announces that Goldstein & Associates Has Joined Its Arbor Point Advisors Hybrid RIA Platform Business Wire - 12/12/2019 9:56:00 AM
Marinus Pharmaceuticals Announces Pricing of $65 Million Public Offering of Common Stock and Concurrent Private Placement GlobeNewswire Inc. - 12/11/2019 9:00:10 AM
Ladenburg Declares Quarterly Dividend on Common Stock Business Wire - 12/6/2019 8:30:00 AM
Securities America Allies with Veteran Executive David Pintaric to Launch New Super-OSJ Business Wire - 11/26/2019 7:00:00 AM
Triad Advisors Successfully Recruits Hybrid Wealth Management Practice Strategic Wealth Advisors PR Newswire (US) - 11/21/2019 6:00:00 AM
Yield10 Bioscience Announces Closing of $11.5 Million Equity Offering and Full Exercise of Over-allotment Option GlobeNewswire Inc. - 11/19/2019 5:35:00 PM
WeissLaw LLP Investigates Ladenburg Thalmann Financial Services Inc. PR Newswire (US) - 11/19/2019 1:06:00 PM
Yield10 Bioscience Announces Pricing of $10.75 Million Equity Offering GlobeNewswire Inc. - 11/15/2019 8:20:00 AM
Rowley Law PLLC is Investigating Proposed Acquisition of Ladenburg Thalmann Financial Services Inc. PR Newswire (US) - 11/12/2019 1:28:00 PM
Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Ladenburg Thalmann Financial Services Inc. has obtained a Fair ... PR Newswire (US) - 11/12/2019 12:32:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/12/2019 6:32:16 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/12/2019 6:31:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/12/2019 6:31:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/12/2019 6:31:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 6:31:09 AM
Advisor Group And Ladenburg Thalmann Announce Merger To Create A Wealth Management Industry Leader With Nearly 11,500 Financi... PR Newswire (US) - 11/11/2019 7:35:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 4:54:35 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2019 8:06:20 AM
Ladenburg Reports Third Quarter 2019 Financial Results Business Wire - 11/8/2019 8:00:00 AM
CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 11/4/2019 9:19:00 AM
KMS Financial Services Adds Patrick Funke & Associates PR Newswire (US) - 10/24/2019 6:00:00 AM
Ladenburg Institute Of Women & Finance Concludes 8th Annual Symposium To Create Opportunities And Build Community For Women A... PR Newswire (US) - 10/17/2019 6:00:00 AM
Securities America Announces That Knight Investments Group Has Joined Its Platform Business Wire - 10/8/2019 6:00:00 AM
Gladstone Capital Corporation Announces Notes Offering GlobeNewswire Inc. - 10/7/2019 9:02:31 AM
investora2z   Thursday, 11/28/13 12:43:49 PM
Re: None
Post # of 138 
The third quarter numbers were very good and the stock has really taken off after that. Topline growth has never been a problem for the company. Even the bottomline was improving recently. It has come closer to reporting a net profit on a full year basis. On a ttm basis, the company has a revenue of $728 million and the net loss is $9.25 million. In 2012, the revenues were around $650 million and the net loss was $16 million. For the nine months ended September 30, 2013, the Company reported revenues of $581 million, up 22% over $478 million for the first nine months of 2012. Net loss attributable to the Company was $3.0 million compared to $14.0 million for the first nine months of 2012. So 2013 is most likely going to be a much better year for Ladenburg. The support of Dr. Frost is always encouraging for investors. Most of his companies' stocks have done great over the last few months. He is always on the lookout for collaboration between his various companies. His company Biozone Pharmaceutical (BZNE) was recently merged with Cocrystal Discovery, another company where Teva (TEVA) and OPKO (OPK) have a stake. Ladenburg has now appreciated by 143% over the last 52 weeks with most of the gains coming in 2013. It has broken out above important hurdles, and one or two good quarters can take it even higher. The market has recognized the potential of the company, and the low percentage of float has helped matters. The valuations are still reasonable, as the market cap to sales is 0.73. The cash on books on September 30 was around $55 million and the debt was around $75 million. So Ladenburg seems to be good for more, though it needs to deliver consistent performance over the next few quarters.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist